Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Westlake Corporation third quarter 2025 earnings conference call. During the presentation, all participants will be in a listen-only mode. After the speaker's remarks, you will be invited to participate in a question and answer session. And as a reminder, ladies and gentlemen, this conference is being recorded today, October 30th, 2025. I would now like to turn the call over to today's host, Jeff Hawley, Westlake's Vice President and Chief Accounting Officer. Sir, you may begin.

Thank you, Stephan. Good morning, everyone, and welcome to the Westlake Corporation Conference Call to discuss our third quarter 2025 results. I'm joined today by Albert Chow, our Executive Chairman, John Mark Gilson, our President and CEO, Steve Bender, our Executive Vice President and Chief Financial Officer, and other members of our management team. During the call, we will refer to our two reporting segments, Performance and Essential Materials, which we refer to as PEM, or Materials, and Housing and Infrastructure Products, which we refer to as HIP, or Products. Today's conference call will begin with John Mark, who will open with a few comments regarding Westlake's performance. Steve will then discuss our financial and operating results, after which John Mark will add a few concluding comments and we'll open the call up to questions. During the third quarter of 2025, we recorded a non-cash impairment charge of $727 million, representing all of the goodwill associated with our North American Chlorovinyls business unit. We also accrued expenses of $17 million related to previously announced facilities closures. We refer to these expense items, which in aggregate were $744 million, as the identified items in our earnings release and on this conference call. References to income from operations, EBITDA, net income, and earnings per share on this call exclude the financial impact of the identified items. As such, comments made on this call will be in regard to our underlying business results using non-GAAP financial measures. A reconciliation of these non-GAAP financial measures to GAAP financial measures is provided in our earnings release, which is available in the investor relations section of our website. Today, management is going to discuss certain topics that will contain forward-looking information based on management's beliefs as well as assumptions made by and information currently available to management. These forward-looking statements suggest predictions or expectations and thus are subject to risks or uncertainties. These risks and uncertainties are discussed in Westlake's Form 10-K for the year into December 31, 2024 and other SEC filings. We encourage you to learn more about these factors that could lead our actual results to differ by reviewing these SEC filings, which are also available on our Investor Relations website. This morning, Westlake issued a press release with details of our third quarter results. This document is available in the press release section of our website at westlake.com. We have also included an earnings presentation, which can be found in the Investor Relations section on our website. A replay of today's call will be available beginning today, two hours following the conclusion of this call. This replay may be accessed via Westlake's website. Please note that information reported on this call speaks only as of today, October 30, 2025, and therefore you are advised that time-sensitive information may no longer be accurate as of the time of any replay. Finally, I would advise you that this conference call is being broadcast live through an internet webcast system that can be accessed on our webpage at westlake.com. Now, I would like to turn the call over to Jean-Marc Gilson. Jean-Marc?

Thank you, Jeff, and good morning, everyone.

We appreciate you joining us to discuss our third quarter 2025 results. For the third quarter of 2025, we reported EBITDA of $313 million on net sales of $2.8 billion. Compared to the second quarter of 2025, sales and EBITDA decreased as improved production and sales volume in our PEM segment was more than offset by lower sales volume in our HIP segment and PEM's lower average selling price. While North American residential construction demand has softened in 2025, HIP sales volume and total sales were comparable to those in 2024. This sales resiliency illustrates the strength of our relationships with key customers and our broad and deep portfolio as we continue to grow in this important market. As compared to the third quarter of 2024, Hips Margin and EBITDA were negatively impacted by a sales mix shift to lower price and lower margin products as our key customers worked to address the home price affordability impact felt by home buyers. In addition, HIPP's EBITDA includes some period-related administrative restructuring and integration expenses in the third quarter of 2025 that are expected to be of a non-recurring nature. Overall, our HIPP business is performing well in light of the affordability headwinds facing the new home construction market. We remain very positive on HIP's long-term growth outlook, supported by the need to rebuild the North American housing stock following over a decade of underbuilding of homes, and we have continued to invest in the HIP business to accelerate our growth. The construction of a new PVCO pipe facility in North Texas to be completed in 2026 and the recently announced acquisition of ACI are some visible examples of our commitment to HIP through these exciting growth-oriented investments. The ACI acquisition significantly expands our global compound business by introducing silicone and cross-linked polyethylene compounds into our portfolio. And it also, importantly, widens our access to new automotive, electrical, and power markets. We expect to close the ACI acquisition in the first quarter of 2026. Turning to PEM, compared to both the prior quarter and prior year periods, our third quarter earnings and margins reflect the soft global demand for many of our PEM products, particularly PVC resins. Our improved operational performance and resulting increase in sales volume in the third quarter helped offset some of the reduction in prices resulting from the global supply-demand imbalance. This global imbalance in supply-demand in the chlorovinyl chain, coupled with the challenging macroeconomic environment, has resulted in an extended trough. As a result, during the third quarter of 2025, we took a non-cash impairment charge of $727 million for all of the goodwill associated with PEMS North American chlorovinyl business. While significant, the charge represents only a small portion of our net investment in the business, and we remain positive in the outlook for chlorovinyls. We remain committed to this business as the global need for its products, which are critical to industries ranging from building materials to water to manufacturing, remains intact. While the current trough continues to persist, we advanced several strategic actions to improve PEMS performance, centered around three key pillars. Number one, improve plant reliability to lower production costs. unit production costs. This pillar is beginning to show results in the third quarter. Two, reduce costs. We are on track to achieve our $150 to $175 million of company-wide structural cost reduction in 2025. And we are taking further actions to achieve another $200 million of structural cost reduction in 2026. Approximately 75% of these cost reductions are attributable to the PEM segment, and these cost reductions will lower PEM's cost and improve our global competitiveness. Three, optimize our manufacturing footprint. We have taken strategic actions to close facilities such as Pernice in the Netherlands and our Wasu PVC resin facility in China. We will take other appropriate asset optimization actions to improve our financial performance as needed. Our relentless focus on these three pillars demonstrates Westlake's continued efforts to adjust our cost structure in response to changing global macroeconomic conditions. Advancing these strategic actions in the coming months is a critical driver to improve our cost and return our PEM segment to levels of profitability that provide an appropriate return on investment. So to summarize the third quarter, our hip businesses continue to perform well and provide a very valuable platform of earning stability, while profitability in our PEM segment is challenged by the ongoing trough. We believe our determined drive to deliver on the elements of this three-pillar strategy will return PEM to profitability, improve the competitiveness of our assets, and deliver the financial performance we expect. I would now like to turn our call over to Steve to provide more detail on our financial results for the third quarter of 2025. Steve?

Thank you, Jean-Marc, and good morning, everyone. As a reminder, my comments regarding the income from operation, EBITDA, net income, and earnings per share all exclude the financial impact of the identified items. Westlake reported a loss of $38 million, or 29 cents per share, in the third quarter on sales of $2.8 billion. The loss in the third quarter of 2025 was $26 million higher than the second quarter of 2025, primarily due to lower average sales price, primarily in PVC resin and our PEMS segment. The challenging global macroeconomic environment and imbalance in supply demand for many of PEMS products has resulted in an extended trough. As a result, during the third quarter of 2025, we took a non-cash impairment charge of $727 million for all of the goodwill associated with PEMS North American Corvinyls business. While this impairment reflects the near-term challenges the North American Corvinal business faces, we believe the cost reduction actions we are taking combined with the improved plant reliability will turn this business to levels of profitability that it is capable of generating. For the third quarter of 2025, our utilization of the FIFO method of accounting resulted in an unfavorable pre-tax impact of $37 million compared to what earnings would have been if we had reported on the LIFO method. This is only an estimate and has not been audited. At a segment level, approximately $32 million of the unfavorable impact was at PIM, and the remaining 5 million unfavorable FIFO impact was at HIP. Before I discuss the details of our segment results, I want to provide some high-level thoughts on the quarter. Our HIP segment performed well, holding sales in line year-over-year despite the slowdown in North American residential construction activity, which highlights our important market position with our key customers, supported by our coast-to-coast market coverage and a wide range of product offerings. While sales were in line with prior year levels, HIP's margins and earnings during the quarter were impacted by unfavorable changes in sales mix and several period-related expenses. Meanwhile, our PIMS segment sales volumes benefited from improved plant reliability compared to the second quarter of 2025. However, average sales prices decreased 4% quarter-over-quarter, which more than offset the impact of the improved sales volumes on segment's earnings. Moving to the specifics of our segment performance, our HIP segment delivered EBITDA of $215 million on $1.1 billion of sales. When compared to the second quarter of 2025, HIPP segment sales volumes were 6% lower, particularly for pipe and fittings, which had exceptionally strong sales volumes in the second quarter of 2025 that may have reflected some pull forward of demand. Sales volumes for global compounds also declined sequentially, driven by slower industrial and manufacturing activity. Meanwhile, demand for siding and trim and roof remained firm. Average sales price for HIP was unchanged sequentially. Lower sales volume, combined with the $20 million period-related expense items and the $5 million FIFO impact that I previously mentioned, drove a decline in HIP's EBITDA margin to 20%. Adjusting for the period-weighted expenses and the FIFO impact, HIP's EBITDA margin in the third quarter of 2025 would have been 22% compared to the 24% in each of the second quarter of 2025 and the third quarter of 2024. Looking at HIP's results on a year-over-year basis, when compared to the third quarter of 2024, HIP's sales fell less than 1% as a 0.5% increase in sales volumes was offset by a 1% decline in average sales price. The year-over-year increase in sales volume, despite the challenging backdrop for North American residential construction, was driven by a solid double-digit sales volume growth in pipe and fittings. And on a year-to-date basis, through the end of the third quarter, pipe and fittings sales volumes have grown nearly 10% as compared to the first three quarters of 2024. Thus, our pipe and fittings business continues to perform very well with a solid outlook for growth, supported by municipal water infrastructure investments and U.S. government funding coming from the infrastructure bill. To summarize HIP's results, the business continues to perform well in the face of the affordability issues surrounding residential construction, and we continue to be pleased with the stability and profitability of this business delivers. We continue to view HIP as a vehicle for inorganic growth, as demonstrated by the recent announcement to acquire ACI's Global Compound Solutions business. ACI brings important technologies and market access, particularly with global automotive manufacturers. We believe that this acquisition will greatly expand the breadth of our product offering and the market reach for Global Compound's business, expanding our sales and earnings Turning to our PIM segment, third quarter sales of $1.7 billion fell by $46 million in the second quarter of 2025, driven by a 4% decline in average sales price that more than offset a 1% increase in sales volume. The decline in average sales price was the result of broadly lower chlorovinyl prices, primarily for PVC resin, and the shift in our sales mix toward export markets, where selling prices tend to be lower. Improved reliability and our global competitive feedstock and energy position in North America drove a 1% sequential increase in sales volume, resulting in a $38 million increase in EBITDA compared to the second quarter of 2025. On a year-over-year basis, PEM's third-quarter sales of $1.7 billion were 13% lower, driven by a 7% decline in average sales price and a 6% decline in sales volumes. As Jean-Marc discussed, the continued softness in global manufacturing and industrial demand, combined with low-priced Asian sales in the global marketplace, have pressured pricing for many of PEMS products, particularly PVC resin. The lower year-over-year average sales price combined with lower sales volume drove a decline in PEMS EBITDA to $90 million in the third quarter of 2025, compared to $297 million in the third quarter of 2024. As Jean-Marc mentioned, we remain confident in our BOTI to improve PEMS results and to deliver meaningful profitability improvement in our PEMS segment. Shifting to our balance sheet, as of September 30, 2025, cash and investments were $2.1 billion and total debt $4.7 billion with a staggered fixed-rate maturity schedule. For the third quarter of 2025, net income provided by operating activities was $182 million, while capital expenditures were $239 million. We continue to look for opportunities to strategically deploy our balance sheet in order to create long-term value. Now, let me provide some guidance for your models. We continue to expect housing and infrastructure products revenue to be in the range of $4.2 to $4.4 billion, with an EBITDA margin between 20% and 22% for 2025. However, given a lower North American residential construction activity and the $20 million of period-related costs incurred in the third quarter, we now expect to be towards the lower end of each of these ranges. We continue to expect total capital expenditures for Westlake in 2025 to be approximately $900 million. Through the end of the third quarter, we achieved approximately $115 million toward our 2025 company-wide structural cost savings target of $150 to $175 million. And we are driving actions now to take an additional $200 million of structural cost reductions by 2026 as part of our PIM profitability improvement strategy. For the full year of 2020-25, we expect cash interest expense to be approximately $160 million. Now, I'd like to turn the call back over to Jean-Marc to provide some thoughts on actions the business is now taking to grow earnings in 2026 and beyond. Jean-Marc?

Thank you, Steve. Looking forward, we are taking proactive steps to improve our financial performance. our HIP segment will continue to execute its successful strategy utilizing three key levers. First, winning with the winners. As we demonstrated this year, even in a slower market, the value of our brands and our broad national footprint delivers significant value for HIP's customers. As a supplier of choice to building product distributors and large national home builders we expect to generate long-term organic sales growth of five to seven percent per annum second new product innovation our head business continues to commercialize breakthrough new technologies that create value for our customers such as our pvco pipe products this advanced This molecular-oriented PVC pipe was introduced in 2021 and has experienced solid customer adoption by delivering water solutions with 40% less PVC. Construction on our new PVC oil plant in North Texas continues with an expected startup in the latter part of 2026 to meet growing customer demand. Third, acquisitions. HIP has demonstrated a proven track record of accretive acquisitions. Our HIP businesses compete in relatively fragmented industries with significant opportunities for both bolt-on and strategic acquisitions. We see significant opportunities to leverage our sales and distribution platforms that are currently in place to create synergies and drive earnings growth. Shifting to PEM, our drive to return this segment to profitability revolves around our three-pillar profitability improvement strategy, which I have already detailed and which is well underway. While we are optimistic that global demand growth for PEM's product will improve, we are squarely focused on actions within our control while the global supply and demand picture improves. This includes improving the reliability of our plants so that we can predictably serve our customers. As a reminder, in 2025, PEMS EBITDA was negatively impacted by approximately $200 million from operating issues. We also have identified significant operational cost savings as part of our company-wide $200 million cost savings target for 2026. Finally, strategic asset optimization actions that we have already taken, such as the Pernit shutdown, are expected to generate over $100 million a year in additional savings starting next year. As we progress into 2026, we will continue to optimize our network and take action when and where necessary to drive improved profitability at our PEM segment. Before I open the call to your questions, I want to close by highlighting Westlake's foundational strengths, which continue to serve us well. These strengths include a diversified and complementary portfolio of businesses, a vertically integrated business model, a globally advantaged feedstock and energy position in the U.S., And our investment-grade rated balance sheet with $2.1 billion of cash and securities. As we end 2025 and transition into 2026, we will continue to capitalize on these strengths to create value for our shareholders. Thank you very much for listening to our third quarter earnings call. I will now turn the call back over to Jeff.

Thank you, John Mark. Before we begin taking questions, I would like to remind listeners that our earnings presentation, which provides additional clarity into our results, is available on our website, and a replay of this teleconference will be available two hours after the call has ended. Stephen, we will now take questions.

Thank you. At this time, we will conduct the question and answer session. And as a reminder, to ask a question, you will need to press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. Please stand by for our first question. Our first question comes from the line of David Biglider of Deutsche Bank. Your line is now open.

Good morning. Jean-Marc, we've seen in polyethylene an increasingly weakening spot market. How will that affect your earnings in the fourth quarter, and what does that mean for, if anything, for the October price increase you have out there for polyethylene?

Yeah, thank you for the question. No, you're right. We are seeing, I would say, a little bit of a weakening in polyethylene prices. At the same time, ethane is still staying in the mid-20s in terms of price. And this is certainly putting pressure on our ethylene margins. There is plenty of supply in the polyethylene segments. We have a very good position, very good operating efficiency in the quarter. We're expecting the same over the next quarter. And we will do our best to gather and create as much value as we can in that segment. So overall, it's been tough, but I would say relatively stable in the ethylene segments. We are, as you expect, the last quarter is always subject also to some seasonality. And that's probably what we're going to see in conjunction with a stable to a little bit lower prices in the last quarter. So that's what we expect getting into the last quarter.

And just for Albert, given the pressures you're seeing in the commodity chemical space, are you on the board still committed to this current portfolio construct with a building products business, with a petrochemical business, or is there thinking that perhaps these businesses are somewhere down the road or best served being separated? Thank you.

Yeah, certainly we are looking at various combinations of business. We believe in the strengths of the two business being together. As we know that our PVC business is a major supplier to our hip business in North America. And we believe that with the balance of supply demand globally improving over the next few years, that with our cost restructuring, our PVC vinyl business in the U.S., we'll be in a much better position to serve our customer both domestically and overseas. And as we see interest rate coming down, it will certainly help the housing construction business in the U.S. that will also improve our head business as well as our PVC business. So we believe there are synergies being together, but we understand from the evaluation of the chemical and construction building material business, they are different. So we are hoping that the market can see some of the parts, but we'll evaluate options as we go. Thank you. You're welcome.

Thank you. Our next question comes from the line of Frank Mitch of Fermium Research. Your line is now open.

Hey, good morning and thank you. You know, you discussed some of the weakness in the polyethylene markets. PBC hasn't exactly been covering itself in glory. What is your near and midterm outlook on the PBC side of things and what will it take to get it back on track?

Yeah. So, yeah, thank you for the question. I'll start and then we'll hand it over to Steve. The forecast for, you're right, I mean, the chlorovinyl chain is being challenged this year with prices going down. And hence, we are taking, I mean, efforts on the cost side to bring, to make sure that we are in a position to compete even at these low prices. So that's why we have started the additional cost savings on top of previous ones. And we are hopeful that we will get back into a position where we will deliver acceptable financial returns in that segment in a not-too-distant future.

And just to add on, Frank, you know, as Jean-Marc was noting, big focus on actions being taken now for cost reductions, improving reliability. We're already seeing those results in the third quarter, and here we are well into the fourth quarter, already seeing improved operating reliability, which allows us to reduce that unit cost. So big efforts on that front. But admittedly, it may take some further supply reductions in the marketplace. And frankly, as you think about what is happening already and been announced in the European market, you've already seen reductions in chloralkali announcements, both in chloralkali as well as in PVC. So I think some of those higher-cost players have already begun to take actions to address the oversupply and high-cost positions.

Thank you so much. And, Steve, if I could follow up on the ACI acquisition. You noted in the release what the sales were in 2024. I was wondering if you might be able to give us an idea of what transpired in 2025. And, you know, are we looking at hip margin type of business? Anything on DNA as we look at model 2026 with the ACI acquisition built into the company?

Yeah, so Frank, good question. And the ACI business is a very strong and it's a global compounding business in that cross-linked polyethylene and silicone business. And it does have good margins in that business. Of course, compounding businesses don't tend to have very high-end ranges of margins, But I would say the range that you're seeing in our HIP segment are reflective of what I would expect to be delivered as we integrate ACI into our business. We think we have compelling synergies with our existing compounds business that is already a global business. And so I do expect the margins that you see in our HIP segment should be reflective of what we achieve once we get these synergies achieved in the ACI acquisition.

Thank you.

You're welcome.

Thank you. Our next question comes from the line of Alexey Iframov of KeyBank Capital Markets. Your line is now open.

Good morning, everyone. I was hoping you could just discuss further in detail the sources of this revision to your HIP guidance and how it affects your maybe initial views of 2026 for the HIP segment.

I'm sorry, Alexey, could I get you to say that again? You were a little faint as you were asking that question.

Oh, apologies. I was just asking why the new HIP guidance is lower, what product lines or what was the reason behind it, and then any initial thoughts on HIP in 26?

Yeah, thank you. Your question initially was a little faint. Thank you for that question. So again, I'd say that with the shifting in product mix that we saw occurred in the third quarter addressing affordability by many of our customers, we saw a shift from the mix of products in that space. And as we think about the period-related costs we had in the third quarter, it also had an impact in the overall 2025 guidance that we have provided. I think a lot of those costs that we had that were period-related are largely non-recurring in nature. And so as we think about the outlook for 2026, our guidance for construction activities is similar to what we've seen in 2025. If you listen to some of the conversations that are occurring publicly with some of our larger home builders nationwide, they're guiding to similar levels of construction activity, and we are believing to work very closely with those home building construction companies. So I think our expectation is while we see rates likely to continue to drift further down on the short end of the curve, I do expect that the longer end of the curve will drift lower, and we do expect there will be more activity in the construction level in 26. But I would still say we expect the range of construction activity to be 1.3 to 1.4 million housing starts, frankly very similar to 2025. But remember, only half of our hip business is new construction. I want to remind you that the other half is repair and remodeling, and the repair and remodeling business has continued to perform very well. So this is why we think that we'll continue to see good continuing performance in 2026.

Thanks, Steve. And I was hoping to get some color on caustic soda market, domestic and export. What is your view for the rest of the year?

So I'd say the market in Caustic is well supplied. We expect that as we look forward into the market, while the consultants have some indication of price momentum, I would expect that pricing in the market remain relatively stable at this stage. But I think the market is well supplied.

I would say the same is true on the chlorine side as well. Thank you.

Our next question comes from the line of Patrick Cunningham of Citi. The line is now open.

Hi, good morning. Maybe just a follow-up on ACI, more of a general question. Are you seeing more opportunities on the PVC compounding or other sort of material side relative to the building product space, just given where the difference in valuations is? And then maybe if you could just comment on what the pipeline in general looks like.

Yeah, I'd say, Patrick, that there are opportunities that we see in expanding the footprint of HIP, both in product offering and ranges, whether they're in the compounding sector or our pipe and fittings businesses or our exterior building products business, the royal business. I'd say there's ongoing good dialogue that we have with parties who may choose to monetize some of those assets. And it's always a function of how does that fit into our business and the associated synergies. So I'd say there's really good opportunity as we look forward, but we're always looking for those synergistic fits into our overall portfolio.

Understood. And then maybe just on the quarter-on-quarter sequential weakness on PBC, you mentioned a shift to export markets. Is this sort of a reversion back to your normal level of exports given the better operating rates, or is there something abnormal here in terms of higher split towards export markets?

No, I think the industry has historically exported PVC resin in the 40s percent of production, and our shift back to some exports was simply improving reliability over the course of the third quarter. And I think going back, as you may recall, our historic levels of exports are below that industry average of 40 or so percent. We're in the mid-30s to low-30s on an average basis. So it's simply just improving reliability, improving production, and putting some of that extra production back into historic market levels as we have in the past. Great. Thank you so much. You're welcome.

Thank you. Our next question comes from the line of John Roberts of Mizuho. Your line is now open.

Thank you.

Did you get an opportunity to bid for the OxyChem business, or was the antitrust there just even too far for this administration and something Oxy maybe didn't want to deal with?

Well, I cannot obviously speak to transactions that we consider. It's a large transaction, and we are a very large player in this space. So we do have to be mindful that there could be regulatory issues around such a transaction. But I would say that we're constantly looking for good opportunities, and certainly whether it be in the HIP side of our business or on the PIM side of the business. But there's always opportunities that we look to to see if there's real synergy value and real opportunities to grow the business in a value-added way.

Thank you. You're welcome. Thank you. Our next question comes from the line of Hassan Ahmad of Olympic Global Advisors. Your line is now open.

Morning, John, Mark, and Steve. You know, just trying to, I know in your prepared remarks, you talked a fair bit about sort of cost savings and asset optimization and the like, but, you know, just trying to get a better sense, you know, of a bridge to 2026, EBITDA-wise. You know, it seems you guys will, you know, get $200 million in cost savings in 2026, an incremental $100 million from the footprint optimization. And, you know, if I heard correctly, you know, you had operational issues in PEM accounting for around $200 million in 2025, which won't be there in 26. So, you know, and then obviously some accretion from the acquisition. So, I mean, is it fair to assume that, you know, via self-help and these things that I just laid out, I mean, on a year-over-year basis, all else equal, you know, EBITDA next year would be $500 million higher than this year?

Yeah, Noah, I think as you think about the pillars that Jean-Marc spoke to and the efforts that we have underway for cost reduction, improved reliability, and asset optimization, I think you've outlined well the guidance that we're trying to speak to in terms of the actions in PIRNUS, the cost reduction initiatives, and the opportunity to improve reliability. And when you think of the reliability challenges, the unplanned outages we had this year, a higher level of planned turnarounds in 2025, but also a number of unplanned outages as well. As we think about 2026, of course there are going to be some planned turnarounds, and of course there could be some unplanned outages. But I think you've outlined the direction that we're moving to improve reliability, reduce our cost, and really act on opportunities to rationalize assets that are not performing well to really improve the bottom line. So I think you've kind of framed the thinking that we have well.

Fair enough. And as a follow-up, kind of linking a couple of the past questions together, I mean, this $727 million impairment, you know, associated with the PEM segment, you know, how should we think about that in light of, you know, some of the valuation data points provided by the OxyChem deal? You know, I mean, obviously, you know, that says something about the fundamentals there, you know, Berkshire coming in and maybe, you know, scooping these assets up at the bottom of the cycle, you know, how does that fit into this impairment you guys took? And again, you know, going back to one of the earlier questions, just potentially thinking about the overall portfolio, is there some sort of valuation leakage with the way the business is set up today?

So the impairment, you know, is a mechanical process process that one has to undertake on an ongoing basis. And when you think about the extended trough that we've seen in the core vinyls business, it was clear to us that that impairment was necessary to be taken. But I think you saw from our prepared remarks that we see the business really in a condition to continue to see good demand over the medium to long term. So we think it really positions the business to continue to return a very solid return on assets as we go forward. And the positioning that we have, we think, is well positioned to capture that value medium to long term. But clearly, we're in this trough conditions today. And those trough conditions really are the drivers behind that impairment. That is really just a mechanical process that one has to undertake on a regular basis. But nevertheless, we think the investment that we've made is well positioned and will continue to really reap the benefits of this investment over time. But that's not to say that we won't make sure all assets are performing well as they should. And if they don't, we'll assess where the right value proposition sits. Very helpful, Steve. Thank you so much.

Welcome.

Thank you. Our next question comes from the line of Josh Spector of UBS.

Your line is now open. yeah good morning um i just wanted to ask around the 20 million of period related expenses and hip can you tell us what exactly that that was and is that really a one quarter cost or is that something that maybe lingers for a few more quarters no i called these out as period related because they really are a large really are administrative and transition and integration related, and so they really are non-recurring in the nature of those items, which is why I call them out as period related.

But would you expect more integration costs in fourth quarter, and are these numbers included in that $200 million reliability bucket you've called out, or is this entirely separate?

I see those. I do not see those at this stage in the fourth quarter, and I don't see those as likely to be near-term repeating.

Okay. Thank you.

You're welcome. Thank you. Our next question comes from the line of Matthew Deo of Bank of America. Your line is now open.

Thanks. How are you thinking about operating rates in polyethylene? Because it feels like the industry is running a bit, I guess, if the industry does run hot, it feels like product starts to back up domestically. And I think we saw that in July and August. But I don't know if I'm extrapolating too much off of shorter duration or shorter, fewer data points. What's your perception there and how do you think about your own utilization rates?

As you think about operating rates, we recognize that operating these plants to service our customers is important, but at the same time, we're going to be operating these facilities in a manner that creates real value. And so if those operating rates are hovering today for the industry in the mid-80s to low-80s, we certainly had some plant maintenance we undertook in the third quarter. And so I would expect that our operating rates for the year will be slightly lower than industry average. But as we think about our polyethylene assets, we'll continue to make sure the operating rates reflect the value add that we see in the marketplace. And if we need to adjust those operating rates accordingly, we will.

Thank you. Our next question comes from the line of Duffy Fisher of Goldman Sachs.

Good morning, guys. If you back into the number four HIP, just with what you've given us, because we've got the year at the low end at the 4-2 and the 20%. You get a little under $150 million, which is down 20% year-on-year, roughly equal to Q3, which was down about 20%. But you don't have the period cost you just said. So how should we think about that back half number basically being a base to grow into 2026? It seems like HIP numbers should be down next year, just given, you know, how low we are in the back half relative to the year. But, you know, any guidance on that would be helpful.

Yeah, so Duffy, you know, we see the seasonal construction period begin to slow in Q4. And so if you think about the new construction activity that typically occurs in the fourth quarter, it tends to be slower. But as we look forward, and again, I just want to remind you that half of our HIP business is repair and remodeling. So it's not entirely tied to the new construction markets that we see the nationwide builders dealing with at this stage. And so we still remain very constructive in our outlook for 2026 in terms of how we see the HIP business continuing to perform. There, of course, is seasonality in the first quarter and in the fourth quarter. So as we look at the fourth quarter that we're in today, going into the early stages of first quarter, there is naturally seasonality. And this is why we're guiding not only to the lower end of this range for the period-related expenses we had in third quarter, but also some of the slowing that we typically see in the fourth quarter. But as we look forward into 2026, recognizing that half our business is new construction, the other half is repair and remodeling, we still remain relatively constructive in our outlook. those uh that constructive outlook is really tied to the dialogue that we're having really with these nationwide builders who while they are working down their completed and unsold inventory still seem to be moving forward with their construction plans fair enough and then if i could just go back to the um the write down um in the pem section you know chlorovinos you know obviously everything has to be forward looking right the fact we've been in a long trough

You know, it's not a backward looking, you know, write down. It's your expectations going forward. So, you know, what's changed, I guess, kind of in your 10-year outlook, you know, for chlorovinyls and how much of the hit is downstream and how much of the hit would be kind of at the chloralkali level? Thank you.

Yeah, this was, of course, just really on a chloralkali base. And so as we think about the discounted cash flows that one has to run for the assessment of goodwill impairment, you can recognize the extended trough we have triggered that impairment. But when we think about the fact there was no impairment of the assets themselves, it signals really the fact that we believe that this business continues to perform and will perform well in the medium to long term. It's just the extended nature of this trough really in the core vinyls business. Great.

Thank you, guys.

You're welcome. Thank you. Our next question comes from the line of Vincent Andrews of Morgan Stanley. Your line is now open.

Hey, good morning. This is Turner Hendricks on for Vincent. So I wanted to level set a little bit for your comments on outages. You all mentioned earlier, of course, the issues constituting around a $200 million impact this year. And you also had the Petro One turnaround, I believe, in addition to that, $80 million. So in the absence of unplanned outages, how are you all thinking about maintenance costs next year relative to this year? And is that the right way of framing it?

Yeah. And so, as I say, 2025 was a much heavier year for planned outages, planned turnarounds. And so as I think about 2026, we don't have an ethylene cracker planned outage for turnaround. We only have some of the smaller units, and those occur on a pretty regular basis every two to three years, whether they are PVC or chloroquine or polyethylene assets, which typically turn every two to three years. And so the relative maintenance expense for turnarounds in 2026 should be much lower than they were in 2025.

Thanks. I think that answers the question. How are you thinking about, if you can provide any color on this, go forward to CapEx, specifically if the market environment remains relatively similar next year to this year, is it safe to assume that CapEx might still be in the $900 million range or perhaps a billion dollar Yeah, we're continuing to finalize our budget plans for 2026, but I would say that I would expect it to be similar in relative size. great thanks so much you're welcome thank you our next question comes from the line of Pete Osterlin of Truist Securities your line is now open hey

good morning thanks for taking the questions within PEM you had a $36 million tailwind from improved plant reliability in the third quarter do you expect this to be a sequential tailwind in fourth quarter as well and and what is a reasonable amount to expect there? Could it be another $35 million or so?

And so while we have seen some improved reliability, I would expect that we'll continue to see improved reliability in the fourth quarter. The amount of that reliability dollar-wise is really attributable to the assumptions that you might have on pricing. And so I have to refer back to you in terms of what your assumptions are for pricing in the model, but we are seeing improved per viability in Q3 and in Q4. So I do expect a tailwind, but the quantification of that is really a function of what pricing assumption you might have in your models.

Got it. Thanks. And then also just wanted to follow up on your plans for the $200 million of cost saves in 26. Could you share the cadence you expect throughout the year for actioning those cost savings? And I guess how much of that $200 million do you expect will actually be realized in 26 EBITDA relative to 2025.

Yeah, and so I do expect actions, I do expect those all to be pocketed in 2026. Actions actually are underway now. And so whether these are actions that relate to supply chain, to feedstock, to wide range of what I would say structural costs that are coming out of the business. So we'll begin to provide a little bit more cover in 26 as we get into the actions in terms of the cadence, but I do fully expect to pocket that $200 million in 2026 because actions clearly are underway well-defined and well-actioned at this stage and beginning to materialize in 26. Of course, we have actions underway for 2025 as well, and as I mentioned, we've had $115 million achieved toward our $150 to $175 million target in 25. So we expect that we're moving forward, And many of these leverage the actions in 2025 that will continue to be additive in 2026.

Thanks a lot. You're welcome.

Thank you. Our next question comes from the line of Matthew Blair of TPH. Your line is now open.

Great. Thank you and good morning. You mentioned a few times the affordability issues in the U.S. housing market. How are you responding here? Are you introducing more low-cost products? Are you changing the raw materials on any of your existing products? Or maybe this doesn't warrant a change in strategy for you, but could you discuss that?

Yeah, and so when you think about our HIP businesses, we do have the range of good, better, best range of products. And that allows us to be able to address the affordability issues that some of the builders may have as they think about trying to address the affordability issues of homes. And so I spoke earlier about some of the product mix shift that we saw in Q3, and that's part of the reasoning behind some of that product mix shift is moving products from maybe good, better, best to be able to address the affordability issues that we see builders approaching us and discussing.

Sounds good. And then could you also discuss why you re-upped the ethylene supply agreement with the MLP? Does this raise costs at a time when the industry is in a tough spot? Or is it the general idea to just preserve your optionality in case the MLP equity markets ever come back? Thank you.

Yeah, good question. But we continue to see, I think, good value in the partnership in its position today. And the extension of this agreement is actually very much as was originally envisioned back in 2014 when we constructed the partnership and launched that into the marketplace. It was designed to have an ability to extend that contract yearly, year after year, as the end of that 12-year contract expires, which is the end of 26. So renewing that contract or moving forward with that is reflective of the original construct of that ethylene sales agreement that was originally put to place in 2014. If you look at the way the contract for the ethylene sales agreement is constructed today, actually we're very close to that $0.10 margin already, so there's really no give up on either side of the equation. The C-Corp as well as the partnership are getting, in effect, market pricing in today's market. And so if you look at cash margin, that's really not how the agreement is structured. It's really on a fully loaded basis. And so that's really where the market is today, and that's why both the C-Corp and the partnership have agreed to extend this contract.

Great. Thank you. You're welcome.

Thank you. Our next question comes from the line of Arun Viswanathan of RBC Capital Markets. Your line is now open.

Aruni, you're there. Thanks for the time. There you are. Yeah, sorry about that, guys. Thanks for the question. So I guess just going back to Caustic, you noted that Caustic is well-supplied and you don't expect a price increase, or I don't know if that's what you said. But, you know, I guess I was under the impression that maybe there was a $50 increase announced and you could get maybe 20 of that in the coming months. Maybe you can just elaborate on what you're seeing there in Caustic Soda.

Thanks. yeah and so around there you know as i said the market is well supplied if you look at where the consultants are with their forecast for prices they do have nominated in their forecast price increases and this is the time of year where you see a curtailment of chlorine production as we reach a slowing season in construction which impacts pbc slowing just because of the seasonality So there is normally a slowdown in the production of chlorine and therefore caustic soda production, which is the basis behind their driver for the price increase. And whether it be one consultant or another, they have roughly $25 a ton in their forecast. And so certainly my comment really was that the market simply is well supplied. And to the extent there are opportunities to improve pricing, we'll certainly act on those.

Right.

Thank you. Our next question comes from the line of Kevin McCarthy, Vertical Research Partners. Your line is now open.

Yes, thank you, and good morning. With epoxy resins having been removed from Annex II, would you provide an update on how you see that market unfolding over the next several quarters?

Yeah, Kevin. You know, with our shuttering of the Pernis facility in Europe and our ability to source feedstocks, both LER and BPA, in a very cost-effective manner, our downstream businesses are beginning to perform much better with that lower-cost input feedstock. And so our European and North American and Asian businesses in epoxy are expected to continue to perform well. The challenge we had in our epoxy business simply was the fact that we had higher cost of production in Europe. So as we see the market today, I see some improvement in overall epoxy pricing, but I'd say our focus these days is very much in the downstream formulated aspects of the epoxy business that we have in Europe, in the Americas, as well as in Asia.

And then as a follow-up or clarification, when exactly will the $100 million of goodness related to the Purness closure begin to flow through? Does that happen in the first quarter, or how would you characterize that?

Yeah, so the losses that we were incurring there, the plant has been shuttered, and we're in the process of bringing the unit down or brought the unit down safely in the third quarter. So the benefits that we're beginning to see are beginning to accrue in Q4 and forward into 2026. So, of course, there'll be some severance costs and such that you'll see flow through, but the benefit that we're seeing to the bottom line will begin to come through in Q4 and into 26.

Very good. Thanks very much. You're welcome.

Thank you. Our next question comes from the line of Michael Cisson of Wells Fargo. Your line is now open.

Hey, guys, I'm just curious. I think I understand some of the pluses for 2026. But if demand stays in the trough, which, you know, a lot of companies have said they haven't seen evidence that we're going to pick back up anytime soon. You noted polyethylene, PVC, caustic chlorine are both oversupplied, and it feels like fee stock cost could go higher. So do you think, you know, margins, industry margins for PEM could go lower in 26, given that scenario?

You know, it's really hard to make that call, Mike. When you think about the market that we see today, the outlook we see, and I'm looking at outlooks from the consultants on pricing, pricing remains fairly stable. If you look at the average price as one of the better-known consultants for 25 and compare that to their forecast for 2026, it's basically flat for the course of 26 versus the year 2025. Certainly we have, and Jean-Marc made comment about this, our feedstock costs have certainly risen, and so you're seeing some higher costs for ethane. And so there could be some further compression, but of course that ethane is going into derivatives downstream. So if those derivatives downstream can't support that higher feedstock, then higher prices may not fully materialize in ethane. But I would say as we look forward, we're certainly looking at our customer demand picture and also looking at what our customers are saying and how we operate the business. But I would say the consultants suggest that prices should be relatively flat from $25 to $26 in the core vinyls business.

Great. Thank you. You're welcome.

Thank you. At this time, the Q&A session has now ended. Are there any closing remarks?

Yes. Thank you again for participating in today's call. We hope you'll join us again for our next conference call to discuss our fourth quarter 2025 results.

Thank you for participating in today's Westlake Corporation third quarter earnings conference call. As a reminder, this call will be available for replay beginning two hours after the call has ended. The replay can be accessed via Westlake's website. Goodbye.